Drug Discovery, Before and After AI - with Kristof Szalay of Turbine.ai

The great and brilliant Dr. Kristof Szalay returns to the podcast. Dr. Szalay is CTO and Founder of Turbine.ai, a simulation-driven drug discovery company, delivering targeted cancer therapies to targeted patient populations. Today's episode topics include: how AI integrates with the phases of drug discovery, development, and generally applicable enterprise deployment challenges. Want to discover opportunities to integrate AI in your organization? Try Emerj Plus: emerj.com/p1